Medicare launches $50 Wegovy pilot with strict eligibility

Medicare launches $50 Wegovy pilot with strict eligibility

The Centers for Medicare & Medicaid Services said that Medicare launched a $50-per-month Wegovy pilot on July 1, 2026, limited to beneficiaries who meet strict BMI and health-condition criteria and are enrolled in an eligible Part D plan. The 18-month demonstration provides coverage for GLP-1 obesity drugs at a $50 monthly copay for eligible seniors, with eligibility based on body-mass-index thresholds and certain health conditions, and is scheduled to run through the end of 2027, as reported by CBS News, CNBC, ABC News and AP News.

Դերակատարներ

Medicare Centers for Medicare & Medicaid Services Eli Lilly Novo Nordisk Juliette Cubanski KFF

Տեղադրություններ

Ոչ մի գրառում

Հոդվածներ

Հուլիս 29, 2026
1 ընդհանուր
As of July 1, Medicare Covers Wegovy for Weight Loss at $50 a Month. The Eligibility List Is Short.
As of July 1, Medicare Covers Wegovy for Weight Loss at $50 a Month. The Eligibility List Is Short.

24/7 Wall St. • 29 Հուլ 12:03

Starting July 1, 2026, Medicare will offer a $50 copay for certain GLP-1 drugs, including Wegovy, but only beneficiaries who meet specific BMI and health-condition requirements and are enrolled in an eligible Part D plan can access the benefit.

Վստահելիություն 72% Մանիպ. 8% Կենտրոն
Հուլիս 1, 2026
2 ընդհանուր
What to know about Medicare's $50 GLP-1 program
What to know about Medicare's $50 GLP-1 program

AP News • 1 Հուլ 11:09

A new Medicare program will provide selected GLP-1 weight-loss medications to qualifying beneficiaries for $50 a month through 2027, with eligibility based on BMI and health conditions.

Վստահելիություն 78% Մանիպ. 8% Կենտրոն
Eligible seniors can get GLP-1s for $50 a month for weight loss alone
Eligible seniors can get GLP-1s for $50 a month for weight loss alone

ABC News - Breaking News, Latest News and Videos • 1 Հուլ 09:14

A new federal pilot program will allow eligible Medicare beneficiaries to obtain GLP-1 medications for obesity at a $50 co-pay per month, beginning in July and running through the end of 2027.

Վստահելիություն 72% Մանիպ. 8% Կենտրոն
Հունիս 30, 2026
1 ընդհանուր
Medicare obesity drug GLP-1 coverage starting July 1
Medicare obesity drug GLP-1 coverage starting July 1

CNBC • 30 Հուն 09:00

A new Medicare demonstration program will pay for GLP-1 obesity medications for eligible seniors at a $50 monthly copayment, but the coverage is set to expire in 2027.

Վստահելիություն 78% Մանիպ. 9% Կենտրոն
Հունիս 29, 2026
1 ընդհանուր
Medicare to cover GLP-1 drugs for weight loss starting July 1. Here's what to know.
Medicare to cover GLP-1 drugs for weight loss starting July 1. Here's what to know.

CBS News • 29 Հուն 19:39

Starting July 1, Medicare will offer an 18-month pilot that pays for certain GLP-1 medications prescribed for obesity, requiring a $50 monthly copay for eligible beneficiaries.

Վստահելիություն 73% Մանիպ. 12% Կենտրոն